1. Home
  2. VNDA vs TATT Comparison

VNDA vs TATT Comparison

Compare VNDA & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • TATT
  • Stock Information
  • Founded
  • VNDA 2002
  • TATT 1985
  • Country
  • VNDA United States
  • TATT Israel
  • Employees
  • VNDA N/A
  • TATT 491
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • TATT Aerospace
  • Sector
  • VNDA Health Care
  • TATT Industrials
  • Exchange
  • VNDA Nasdaq
  • TATT Nasdaq
  • Market Cap
  • VNDA 282.8M
  • TATT 268.4M
  • IPO Year
  • VNDA 2006
  • TATT 1987
  • Fundamental
  • Price
  • VNDA $4.77
  • TATT $25.00
  • Analyst Decision
  • VNDA Strong Buy
  • TATT
  • Analyst Count
  • VNDA 2
  • TATT 0
  • Target Price
  • VNDA $16.50
  • TATT N/A
  • AVG Volume (30 Days)
  • VNDA 652.5K
  • TATT 37.5K
  • Earning Date
  • VNDA 05-07-2025
  • TATT 03-25-2025
  • Dividend Yield
  • VNDA N/A
  • TATT N/A
  • EPS Growth
  • VNDA N/A
  • TATT 43.74
  • EPS
  • VNDA N/A
  • TATT 0.76
  • Revenue
  • VNDA $198,772,000.00
  • TATT $142,909,000.00
  • Revenue This Year
  • VNDA $14.36
  • TATT $33.56
  • Revenue Next Year
  • VNDA $44.53
  • TATT $14.09
  • P/E Ratio
  • VNDA N/A
  • TATT $33.60
  • Revenue Growth
  • VNDA 3.18
  • TATT 36.36
  • 52 Week Low
  • VNDA $3.71
  • TATT $10.61
  • 52 Week High
  • VNDA $6.75
  • TATT $33.37
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 48.67
  • TATT 43.94
  • Support Level
  • VNDA $4.84
  • TATT $23.92
  • Resistance Level
  • VNDA $5.04
  • TATT $26.55
  • Average True Range (ATR)
  • VNDA 0.22
  • TATT 1.55
  • MACD
  • VNDA -0.01
  • TATT 0.03
  • Stochastic Oscillator
  • VNDA 26.32
  • TATT 44.17

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About TATT TAT Technologies Ltd.

TAT Technologies Ltd is a provider of solutions and services to the aerospace and defence industries focused mainly on the four segments: Original equipment manufacturing (OEM); MRO services for heat transfer; MRO services for aviation components; Overhaul and coating of jet engine components. The company designs, develops, and manufactures Heat Exchangers, Cooling Systems, Cold Plates, Vapor-Cycle Air Conditioning Systems (for both land and airborne applications), and flow accessories.

Share on Social Networks: